iiCON is a world leading center for infection innovation and R&D working with industry, academics, and clinicians.
iiCON has raised $12.8M in total funding. The most recent round was Grant. The last funding was announced in March 2024.
iiCON's investors include Liverpool City Region Combined Authority.
iiCON is headquartered in Liverpool, United Kingdom.
iiCON is a world leading center for infection innovation and R&D working with industry, academics, and clinicians.
iiCON is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"iiCON — Funding & Investors." VCBacked, March 12, 2024, https://www.vcbacked.co/company/iicon. Accessed September 30, 2026.
VCBacked. (2024). iiCON — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/iicon
{{cite web |title=iiCON — Funding & Investors |url=https://www.vcbacked.co/company/iicon |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated